InvestorsHub Logo
Followers 4
Posts 2010
Boards Moderated 0
Alias Born 09/19/2008

Re: CYRXorbust post# 10960

Monday, 11/27/2017 7:44:15 PM

Monday, November 27, 2017 7:44:15 PM

Post# of 12137
CB, It's frustrating, I think our stock should currently be trading at least 2 points higher.. Let me play devils advocate for a moment.. The CEO guided the KITE and NVS commercializations.. 8-10 million peak per account..
Guided Jackson Labs, 600 shipments annually, I believe..
Management has NOT presented the opportunities with Merck, Sanofi or BMY.. WE would all like to know more about these three accounts.. I would like to know more about the 2-8 potential..Another reason I bring a company like McKesson up, McKesson moves a lot of 2-8... The whole sale distributors in general move a lot in the 2-8 range.

I think the reason for the current price stagnation is the Deutsche rumor.. Do we need additional capital or don't we.. The buyers stepped away following the Fly and have not be back.. Management should address this issue. With 15 million in the bank and no debt, hard to believe we need additional funds at this moment.. But as long as management remains silence, the market will see it for what it is..

While technical analysis is not my strong set, I've been learning to read the charts, I like our set up.. One positive piece of news could get us back to the high 7's or even low 8's.. I will defer to the technical experts for their opinion as well..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News